NCI-H647 Cells
CAD$759.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | NCI-H647 cells are a human lung carcinoma cell line derived from a patient with large cell carcinoma of the lung. This cell line is part of the NCI (National Cancer Institute) panel of human tumor cell lines used extensively in cancer research, particularly in studies concerning lung cancer biology and therapeutics. The NCI-H647 cell line exhibits characteristics typical of large cell lung carcinoma, including rapid growth and the ability to form tumors when xenografted into immunocompromised mice. These cells are particularly useful for exploring the molecular mechanisms of lung cancer pathogenesis, including signal transduction pathways, genetic mutations involved in cancer progression, and the role of tumor microenvironment factors. NCI-H647 cells are often employed in drug screening studies to evaluate the efficacy and toxicity of chemotherapeutic agents and targeted therapies. Their responsiveness to various anti-cancer compounds helps in understanding the pharmacodynamics and potential resistance mechanisms of lung cancer treatments. This cell line is also used to study the interaction between cancer cells and therapeutic agents, providing insights into the development of more effective and personalized treatment strategies for lung cancer patients. Overall, the NCI-H647 cell line serves as a critical tool in lung cancer research, facilitating advancements in understanding the disease and developing novel therapeutic approaches. |
|---|---|
| Organism | Human |
| Tissue | Lung |
| Disease | Lung adenosquamous carcinoma |
| Metastatic site | Pleural effusion |
| Synonyms | NCI-H647, H-647, H647ell, NCIH647 |
Characteristics
| Age | 56 years |
|---|---|
| Gender | Male |
| Ethnicity | European |
| Morphology | Epithelial |
| Growth properties | Adherent |
Regulatory Data
| Citation | NCI-H647 (Cytion catalog number 305130) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1574 |
Biomolecular Data
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Fluid renewal | 2 to 3 times per week |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificate of Analysis (CoA)
| Lot Number | Certificate Type | Date | Catalog Number |
|---|---|---|---|
| 305130-230224 | Certificate of Analysis | 23. May. 2025 | 305130 |
| 305130-170325 | Certificate of Analysis | 23. May. 2025 | 305130 |
-
Related products
Related products